Anapharm is an industry leader in early-phase drug development, providing a wide range of services to the pharmaceutical, biotechnology, and generic-drug industries. Anapharm offers a vast array of bioanalytical laboratory services, as well as services in Phase I clinical development, bioequivalence, and regulatory affairs.

As a PharmaNet Development Group company, Anapharm has access to a global network of resources for Phase I–IV consulting and clinical drug development.